IL78739A - Ascorbic acid derivatives and pharmaceutical compositions containing them - Google Patents
Ascorbic acid derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL78739A IL78739A IL78739A IL7873986A IL78739A IL 78739 A IL78739 A IL 78739A IL 78739 A IL78739 A IL 78739A IL 7873986 A IL7873986 A IL 7873986A IL 78739 A IL78739 A IL 78739A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- ascorbic acid
- compositions containing
- acid derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1985/000272 WO1986006720A1 (fr) | 1985-05-17 | 1985-05-17 | Derives d'acide ascorbique, production desdits derives et preparation pharmaceutique pouvant en resulter |
PCT/JP1985/000340 WO1986007592A1 (fr) | 1985-06-18 | 1985-06-18 | Derives d'acide ascorbique, leur procede de preparation, et preparations les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
IL78739A0 IL78739A0 (en) | 1986-08-31 |
IL78739A true IL78739A (en) | 1993-01-31 |
Family
ID=26425982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL78739A IL78739A (en) | 1985-05-17 | 1986-05-09 | Ascorbic acid derivatives and pharmaceutical compositions containing them |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0202589B1 (fr) |
JP (1) | JPH0739342B2 (fr) |
KR (1) | KR940000073B1 (fr) |
CN (1) | CN1014409B (fr) |
AU (1) | AU599029B2 (fr) |
CA (1) | CA1293728C (fr) |
DE (1) | DE3669104D1 (fr) |
ES (1) | ES8801643A1 (fr) |
FI (1) | FI862029A (fr) |
GR (1) | GR861228B (fr) |
HU (1) | HU197735B (fr) |
IE (1) | IE59143B1 (fr) |
IL (1) | IL78739A (fr) |
NO (1) | NO172343C (fr) |
PH (1) | PH24833A (fr) |
PT (1) | PT82591B (fr) |
ZA (1) | ZA852614B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
US4826872A (en) * | 1986-12-03 | 1989-05-02 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for treatment of cataract |
PH25859A (en) * | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
JPH01228978A (ja) * | 1988-03-09 | 1989-09-12 | Nippon Hai Potsukusu:Kk | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
US4939128A (en) * | 1988-04-25 | 1990-07-03 | Takeda Chemical Industries, Ltd. | Ester of ascorbic acid 2-phosphate and pharmaceutical use |
JP2830268B2 (ja) * | 1989-01-21 | 1998-12-02 | 武田薬品工業株式会社 | アスコルビン酸誘導体の製造法 |
US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
EP0446539A1 (fr) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Dérivé de l'acide ascorbique |
EP0467691A1 (fr) * | 1990-07-20 | 1992-01-22 | Takeda Chemical Industries, Ltd. | Dérivés d'acide saccharoascorbique et leur utilisation |
WO1993004055A2 (fr) * | 1991-08-27 | 1993-03-04 | The Upjohn Company | Composes utilises pour inhiber la vih protease |
JPH0656669A (ja) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | 活性酸素消去作用を持つプテリン誘導体製剤 |
TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
JPH09502713A (ja) * | 1993-09-17 | 1997-03-18 | ジ・アップジョン・カンパニー | Hivおよび他のレトロウイルス病を治療するのに有用な置換テトロン酸 |
JPH07188024A (ja) * | 1993-12-27 | 1995-07-25 | Asahi Breweries Ltd | 脳循環障害治療剤 |
FR2715156B1 (fr) * | 1994-01-20 | 1996-03-01 | Oreal | Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires. |
DK0817786T3 (da) * | 1995-03-20 | 2003-05-26 | Upjohn Co | Substituerede tetronsyrer, der er nyttige til behandling af HIV og andre retrovira |
AU5317296A (en) * | 1995-03-24 | 1996-10-16 | Francis V. Defeudis | Methods for treating conditions associated with excess nitri c oxide |
GB2321455A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
KR100440191B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 항산화 효과 및 높은 안정성을 갖는 아스코르브산 유도체및 그것의 제조방법 |
KR100440190B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 아카비오신-글루코실 아스코르베이트 및 그의 제조방법 |
BRPI0409628A (pt) * | 2003-04-21 | 2006-04-25 | Tagra Biotechnologies Ltd | derivados estabilizados de ácido ascórbico |
FR2946252B1 (fr) * | 2009-06-08 | 2011-07-29 | Fabre Pierre Dermo Cosmetique | Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques |
WO2012157656A1 (fr) * | 2011-05-18 | 2012-11-22 | 三菱瓦斯化学株式会社 | Absorbeur d'oxygène |
FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
EP2902387A1 (fr) * | 2012-09-27 | 2015-08-05 | Nippon Soda Co., Ltd. | Composé associé à l'acide ascorbique et agent dirigé contre les virus affectant les plantes |
KR20180089459A (ko) | 2015-12-03 | 2018-08-08 | 쓰리엠 이노베이티브 프로퍼티즈 캄파니 | 광불안정성 환원제를 갖는 산화 환원 중합성 조성물 |
KR102154487B1 (ko) * | 2017-05-24 | 2020-09-10 | 쓰리엠 이노베이티브 프로퍼티즈 캄파니 | 접착 물품 및 그의 제조 및 사용 방법 |
JP6986375B2 (ja) * | 2017-06-22 | 2021-12-22 | 章博 田井 | 抗アレルギー剤、メディエーター遊離阻害剤及び内服薬 |
JP7140325B2 (ja) | 2018-05-23 | 2022-09-21 | 株式会社らいむ | 化合物、抗アレルギー剤およびメディエーター遊離阻害剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1016834A (en) * | 1962-11-26 | 1966-01-12 | Nihon Surfactant Ind Company L | Improvements in or relating to 2.6 diesters of ascorbic acid or isoascorbic acid |
DE1518988A1 (de) * | 1965-05-07 | 1969-12-11 | Herbert Ohg A | Verfahren zur Herstellung von Di- und Triestern der Ascorbinsaeure |
JPS49833B1 (fr) * | 1970-09-01 | 1974-01-10 | ||
JPS4867268A (fr) * | 1971-12-20 | 1973-09-13 | ||
JPS5719109B2 (fr) * | 1973-07-19 | 1982-04-20 | ||
US4164585A (en) * | 1976-07-01 | 1979-08-14 | Cardioquest Corporation | Anti-thrombotic compound and method of making and using the same for pharmaceutical purposes |
JPS5692260A (en) * | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic ester and its preparation |
JPS57156479A (en) * | 1981-03-24 | 1982-09-27 | Santen Pharmaceut Co Ltd | Ascorbic acid derivative |
JPS601175A (ja) * | 1983-06-16 | 1985-01-07 | Daikin Ind Ltd | アスコルビン酸誘導体 |
JPS6023307A (ja) * | 1983-07-15 | 1985-02-05 | Kanebo Ltd | 美白化粧料 |
JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤,アスコルビン酸誘導体およびその製造法 |
JPS60237083A (ja) * | 1984-05-08 | 1985-11-25 | Kao Corp | アスコルビン酸エステル |
-
1985
- 1985-04-09 ZA ZA852614A patent/ZA852614B/xx unknown
-
1986
- 1986-05-09 IL IL78739A patent/IL78739A/xx not_active IP Right Cessation
- 1986-05-12 AU AU57350/86A patent/AU599029B2/en not_active Ceased
- 1986-05-12 GR GR861228A patent/GR861228B/el unknown
- 1986-05-13 PH PH33764A patent/PH24833A/en unknown
- 1986-05-14 DE DE8686106521T patent/DE3669104D1/de not_active Expired - Fee Related
- 1986-05-14 FI FI862029A patent/FI862029A/fi not_active Application Discontinuation
- 1986-05-14 EP EP86106521A patent/EP0202589B1/fr not_active Expired - Lifetime
- 1986-05-15 PT PT82591A patent/PT82591B/pt not_active IP Right Cessation
- 1986-05-15 JP JP61111945A patent/JPH0739342B2/ja not_active Expired - Lifetime
- 1986-05-16 NO NO861956A patent/NO172343C/no unknown
- 1986-05-16 HU HU862087A patent/HU197735B/hu not_active IP Right Cessation
- 1986-05-16 IE IE131386A patent/IE59143B1/en not_active IP Right Cessation
- 1986-05-16 CA CA000509360A patent/CA1293728C/fr not_active Expired - Lifetime
- 1986-05-16 ES ES555014A patent/ES8801643A1/es not_active Expired
- 1986-05-17 CN CN86103398A patent/CN1014409B/zh not_active Expired
- 1986-05-17 KR KR1019860003855A patent/KR940000073B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0202589A3 (en) | 1987-10-07 |
CN1014409B (zh) | 1991-10-23 |
EP0202589A2 (fr) | 1986-11-26 |
NO172343B (no) | 1993-03-29 |
NO172343C (no) | 1993-07-07 |
ZA852614B (en) | 1986-10-09 |
IE861313L (en) | 1986-11-17 |
JPH0739342B2 (ja) | 1995-05-01 |
FI862029A0 (fi) | 1986-05-14 |
GR861228B (en) | 1986-09-15 |
ES8801643A1 (es) | 1988-02-16 |
CA1293728C (fr) | 1991-12-31 |
AU599029B2 (en) | 1990-07-12 |
PT82591B (pt) | 1988-11-30 |
KR860009001A (ko) | 1986-12-19 |
JPS61263969A (ja) | 1986-11-21 |
FI862029A (fi) | 1986-11-18 |
PT82591A (en) | 1986-06-01 |
EP0202589B1 (fr) | 1990-02-28 |
KR940000073B1 (ko) | 1994-01-05 |
IL78739A0 (en) | 1986-08-31 |
NO861956L (no) | 1986-11-18 |
DE3669104D1 (de) | 1990-04-05 |
HU197735B (en) | 1989-05-29 |
IE59143B1 (en) | 1994-01-12 |
CN86103398A (zh) | 1986-12-03 |
HUT44249A (en) | 1988-02-29 |
PH24833A (en) | 1990-10-30 |
ES555014A0 (es) | 1988-02-16 |
AU5735086A (en) | 1986-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL78739A (en) | Ascorbic acid derivatives and pharmaceutical compositions containing them | |
NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
NZ220345A (en) | Imidazoquinolinylether derivatives and pharmaceutical compositions containing them | |
IL80296A (en) | Phenylpyridone derivatives,their preparation and pharmaceutical compositions containing them | |
IL78942A0 (en) | Thiazolidinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
IL74865A0 (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
IL78872A0 (en) | Morphinan derivatives and pharmaceutical compositions containing them | |
IL79376A (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them | |
IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
IL82205A (en) | Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them | |
IL76188A (en) | 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them | |
IL79402A (en) | Poly-4-aminopyrrole-2-carboxamido derivatives,their preparation and pharmaceutical compositions containing them | |
IL79236A0 (en) | Pharmaceutical compositions containing vitamin d derivatives | |
IL77849A0 (en) | Aryldihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
IL86711A0 (en) | 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them | |
NZ225466A (en) | 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof | |
GB2167414B (en) | Flavolignan derivatives and pharmaceutical compositions containing them | |
NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
IL80540A0 (en) | Dihydropyridine derivatives and pharmaceutical compositions containing them | |
IL79003A0 (en) | Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them | |
EP0191735A3 (en) | Novel oxaluric acid derivatives and pharmaceutical compositions containing them | |
NZ214815A (en) | 12-aminopyridazinopyrroloisoquinoline derivatives and pharmaceutical compositions | |
IL77799A0 (en) | Dihydropyridinedicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them | |
IL79377A0 (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |